We serve Chemical Name:2-(2-Formyl-4-nitrophenoxy)hexanoic acid CAS:335153-21-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(2-Formyl-4-nitrophenoxy)hexanoic acid
CAS.NO:335153-21-4
Synonyms:2-(2-formyl-4-nitro-phenoxy)-hexanoic acid
Molecular Formula:C13H15NO6
Molecular Weight:281.26100
HS Code:2918990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:475ºC at 760 mmHg
Density:1.311g/cm3
Index of Refraction:1.575
PSA:109.42000
Exact Mass:281.09000
LogP:2.95270
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(2-formyl-4-nitro-phenoxy)-hexanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-formyl-4-nitro-phenoxy)-hexanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-formyl-4-nitro-phenoxy)-hexanoic acid Use and application,2-(2-formyl-4-nitro-phenoxy)-hexanoic acid technical grade,usp/ep/jp grade.
Related News: The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development. 2-(2-Formyl-4-nitrophenoxy)hexanoic acid manufacturer She said she revealed her diagnosis in the interest of transparency but in truth really mostly as a shoutout to early diagnosis,” and wanted to “urge women to educate themselves on this disease; to get all the regular screenings and scans that you can; to always listen to your bodies; and of course to ensure that your legitimate medical concerns are not dismissed or diminished. 2-(2-Formyl-4-nitrophenoxy)hexanoic acid supplier The U.S. laws governing cosmetics safety and labelling date back to 1938 and 1967, which tells you something,” Bruton said.
However, on Tuesday, Sens. Susan Collins (R-Maine) and Richard Blumenthal (D-Conn.) introduced the No PFAS in Cosmetics Act in the Senate, the Washington Post reported. The same bill was introduced in the U.S. House by Rep. Debbie Dingell (D-Michigan). It would direct the U.S. Food and Drug Administration to issue a proposed rule banning the intentional addition of PFAS in cosmetics within 270 days of the bill’s passage, and require a final rule to be issued 90 days later.
“Our bill would require the FDA to ban the addition of PFAS to cosmetics products,” Collins said in a statement. “Americans should be able to trust that the products they are applying to their hair or skin are safe. 2-(2-Formyl-4-nitrophenoxy)hexanoic acid vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 2-(2-Formyl-4-nitrophenoxy)hexanoic acid factory China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.
However, on Tuesday, Sens. Susan Collins (R-Maine) and Richard Blumenthal (D-Conn.) introduced the No PFAS in Cosmetics Act in the Senate, the Washington Post reported. The same bill was introduced in the U.S. House by Rep. Debbie Dingell (D-Michigan). It would direct the U.S. Food and Drug Administration to issue a proposed rule banning the intentional addition of PFAS in cosmetics within 270 days of the bill’s passage, and require a final rule to be issued 90 days later.
“Our bill would require the FDA to ban the addition of PFAS to cosmetics products,” Collins said in a statement. “Americans should be able to trust that the products they are applying to their hair or skin are safe. 2-(2-Formyl-4-nitrophenoxy)hexanoic acid vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 2-(2-Formyl-4-nitrophenoxy)hexanoic acid factory China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.
